Search

Your search keyword '"Pérol, M."' showing total 10 results
Start Over Author "Pérol, M." Topic metastasis
10 results on '"Pérol, M."'

4. 509MO Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01.

Author

Ahn, M-J., Lisberg, A.E., Paz-Ares, L., Cornelissen, R., Girard, N., Pons-Tostivint, E., Vicente Baz, D., Sugawara, S., Cobo Dols, M., Pérol, M., Mascaux, C., Poddubskaya, E., Kitazono, S., Hayashi, H., Sands, J., Hall, R., Zhang, Y., Zebger-Gong, H., Uema, D., and Okamoto, I.

Subjects
*NON-small-cell lung carcinoma, *DOCETAXEL, *METASTASIS
Published
2023
Full Text
View/download PDF

5. LBA12 Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01.

Author

Ahn, M-J., Lisberg, A., Paz-Ares, L., Cornelissen, R., Girard, N., Pons-Tostivint, E., Vicente Baz, D., Sugawara, S., Cobo Dols, M., Pérol, M., Mascaux, C., Poddubskaya, E., Kitazono, S., Hayashi, H., Sands, J., Hall, R., Zhang, Y., Zebger-Gong, H., Uema, D., and Okamoto, I.

Subjects
*NON-small-cell lung carcinoma, *DOCETAXEL, *METASTASIS
Published
2023
Full Text
View/download PDF

6. 1321MO Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2 (ERBB2)-mutant (HER2m) metastatic non–small cell lung cancer (NSCLC) with and without brain metastases (BMs): Pooled analyses from DESTINY-Lung01 and DESTINY-Lung02.

Author

Li, B.T., Planchard, D., Goto, K., Smit, E.F., De Langen, J., Goto, Y., Ninomiya, K., Kubo, T., Pérol, M., Felip, E., Hayashi, H., Nakagawa, K., Shimizu, J., Nagasaka, M., Pereira, K.M.C., Taguchi, A., Ali, A., Karnoub, M., Yonemochi, R., and Jänne, P.A.

Subjects
*NON-small-cell lung carcinoma, *TRASTUZUMAB, *METASTASIS
Published
2023
Full Text
View/download PDF

8. 976P Phase II trial of trastuzumab deruxtecan (T-DXd) in patients (Pts) with HER2-mutated (HER2m) metastatic non-small cell lung cancer (NSCLC): Registrational data from DESTINY-Lung01.

Author

Li, B.T., Smit, E.F., Goto, Y., Nakagawa, K., Goto, K., Mazieres, J., Uprety, D., Bazhenova, L., Saltos, A., Felip, E., Pacheco, J., Pérol, M., Paz-Ares, L., Saxena, K., Shiga, R., Cheng, Y., Yan, Q., Planchard, D., and Jänne, P.A.

Subjects
*NON-small-cell lung carcinoma, *TRASTUZUMAB, *METASTASIS
Published
2022
Full Text
View/download PDF

9. 1842P Molecular testing in older patients treated for an advanced or metastatic non-squamous non-small cell lung cancer.

Author

Lamy, T., Cabarrou, B., Planchard, D., Quantin, X., Schneider, S., Bringuier, M., Besse, B., Pérol, M., Girard, N., Schott, R., Chouaid, C., Ricordel, C., Gervais, R., Debieuvre, D., Audigier-Valette, C., Carton, M., Filleron, T., Simon, G., Robain, M., and Baldini, C.

Subjects
*NON-small-cell lung carcinoma, *OLDER patients, *METASTASIS
Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results